- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | -1.52 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2022 (9) | -1.94 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2021 (8) | -1.57 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2020 (7) | -2.44 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2019 (6) | -1.85 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2018 (5) | -1.60 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2017 (4) | -1.88 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2016 (3) | -0.81 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
23Q4 (20) | -0.78 | -457.14 | 21.21 | -0.65 | -983.33 | 16.67 | -1.52 | -100.0 | 21.65 |
23Q3 (19) | -0.14 | 53.33 | -7.69 | -0.06 | 71.43 | 50.0 | -0.76 | -18.75 | 20.83 |
23Q2 (18) | -0.30 | 11.76 | 33.33 | -0.21 | 12.5 | 41.67 | -0.64 | -88.24 | 22.89 |
23Q1 (17) | -0.34 | 65.66 | 10.53 | -0.24 | 69.23 | 33.33 | -0.34 | 82.47 | 10.53 |
22Q4 (16) | -0.99 | -661.54 | -135.71 | -0.78 | -550.0 | -212.0 | -1.94 | -102.08 | -23.57 |
22Q3 (15) | -0.13 | 71.11 | 69.05 | -0.12 | 66.67 | 60.0 | -0.96 | -15.66 | 17.24 |
22Q2 (14) | -0.45 | -18.42 | -200.0 | -0.36 | 0.0 | 26.53 | -0.83 | -118.42 | -69.39 |
22Q1 (13) | -0.38 | 9.52 | -11.76 | -0.36 | -44.0 | 2.7 | -0.38 | 75.8 | -11.76 |
21Q4 (12) | -0.42 | 0.0 | 28.81 | -0.25 | 16.67 | 50.98 | -1.57 | -35.34 | 35.66 |
21Q3 (11) | -0.42 | -180.0 | 4.55 | -0.30 | 38.78 | 56.52 | -1.16 | -136.73 | 37.3 |
21Q2 (10) | -0.15 | 55.88 | 77.27 | -0.49 | -32.43 | -590.0 | -0.49 | -44.12 | 65.25 |
21Q1 (9) | -0.34 | 42.37 | 54.67 | -0.37 | 27.45 | 35.09 | -0.34 | 86.07 | 54.67 |
20Q4 (8) | -0.59 | -34.09 | 41.58 | -0.51 | 26.09 | 55.65 | -2.44 | -31.89 | -31.89 |
20Q3 (7) | -0.44 | 33.33 | -588.89 | -0.69 | -790.0 | -56.82 | -1.85 | -31.21 | -120.24 |
20Q2 (6) | -0.66 | 12.0 | -69.23 | 0.10 | 117.54 | 115.62 | -1.41 | -88.0 | -51.61 |
20Q1 (5) | -0.75 | 25.74 | -38.89 | -0.57 | 50.43 | 13.64 | -0.75 | 59.46 | -38.89 |
19Q4 (4) | -1.01 | -1222.22 | 0.0 | -1.15 | -161.36 | 0.0 | -1.85 | -120.24 | 0.0 |
19Q3 (3) | 0.09 | 123.08 | 0.0 | -0.44 | 31.25 | 0.0 | -0.84 | 9.68 | 0.0 |
19Q2 (2) | -0.39 | 27.78 | 0.0 | -0.64 | 3.03 | 0.0 | -0.93 | -72.22 | 0.0 |
19Q1 (1) | -0.54 | 0.0 | 0.0 | -0.66 | 0.0 | 0.0 | -0.54 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/3 | 0.66 | 13.05 | 3.58 | 1.83 | 15.38 | 1.83 | N/A | - | ||
2024/2 | 0.58 | -0.54 | -2.64 | 1.17 | 23.3 | 1.65 | N/A | - | ||
2024/1 | 0.59 | 20.4 | 67.8 | 0.59 | 67.8 | 1.59 | N/A | 113年銷售訂單較去年同期增加 | ||
2023/12 | 0.49 | -6.32 | 86.91 | 6.76 | 25.09 | 1.6 | 1.55 | 112年銷售訂單較去年同期有逐步增加 | ||
2023/11 | 0.52 | -12.53 | 36.1 | 6.27 | 21.97 | 1.73 | 1.43 | - | ||
2023/10 | 0.59 | -4.26 | 20.92 | 5.75 | 18.21 | 1.81 | 1.37 | - | ||
2023/9 | 0.62 | 4.01 | 30.32 | 5.16 | 20.83 | 1.77 | 1.68 | - | ||
2023/8 | 0.6 | 7.12 | 10.51 | 4.54 | 19.64 | 1.8 | 1.65 | - | ||
2023/7 | 0.56 | -14.59 | -0.61 | 3.95 | 21.15 | 1.79 | 1.65 | - | ||
2023/6 | 0.65 | 10.82 | 24.23 | 3.39 | 25.66 | 1.81 | 1.85 | - | ||
2023/5 | 0.59 | 3.37 | 15.75 | 2.74 | 26.01 | 1.79 | 1.86 | - | ||
2023/4 | 0.57 | -10.53 | 14.15 | 2.15 | 29.13 | 1.8 | 1.85 | - | ||
2023/3 | 0.64 | 6.25 | 40.77 | 1.58 | 35.53 | 1.58 | 2.27 | - | ||
2023/2 | 0.6 | 71.43 | 56.48 | 0.95 | 32.22 | 1.21 | 2.97 | 因1月農曆過年假較多來不及出貨於2月出 | ||
2023/1 | 0.35 | 34.11 | 4.46 | 0.35 | 4.46 | 0.99 | 3.63 | - | ||
2022/12 | 0.26 | -31.78 | -10.24 | 5.4 | 18.6 | 1.13 | 2.92 | - | ||
2022/11 | 0.38 | -22.28 | -13.26 | 5.14 | 20.56 | 1.35 | 2.45 | - | ||
2022/10 | 0.49 | 3.17 | 26.9 | 4.87 | 27.2 | 1.51 | 2.19 | - | ||
2022/9 | 0.48 | -11.79 | 4.1 | 4.27 | 24.17 | 1.57 | 2.03 | - | ||
2022/8 | 0.54 | -3.66 | 11.02 | 3.8 | 27.24 | 1.62 | 1.97 | - | ||
2022/7 | 0.56 | 6.76 | 36.37 | 3.26 | 30.39 | 1.59 | 2.0 | - | ||
2022/6 | 0.52 | 3.25 | 58.58 | 2.7 | 29.21 | 1.53 | 1.81 | 隨疫情漸趨緩,訂單增加,致使營收成長。 | ||
2022/5 | 0.51 | 1.94 | 71.05 | 2.17 | 23.69 | 1.46 | 1.9 | 隨疫情漸趨緩,訂單增加,致使營收成長。 | ||
2022/4 | 0.5 | 10.33 | 15.0 | 1.67 | 14.06 | 1.33 | 2.08 | - | ||
2022/3 | 0.45 | 18.11 | 28.77 | 1.17 | 13.66 | 1.17 | 2.74 | - | ||
2022/2 | 0.38 | 14.44 | 7.46 | 0.72 | 5.84 | 1.01 | 3.18 | - | ||
2022/1 | 0.33 | 15.22 | 4.04 | 0.33 | 4.04 | 1.06 | 3.01 | - | ||
2021/12 | 0.29 | -34.07 | -41.53 | 4.56 | -6.78 | 1.12 | 3.05 | - | ||
2021/11 | 0.44 | 13.7 | 18.68 | 4.27 | -2.86 | 1.28 | 2.65 | - | ||
2021/10 | 0.39 | -15.35 | 19.23 | 3.83 | -4.84 | 1.33 | 2.56 | - | ||
2021/9 | 0.46 | -5.94 | 14.3 | 3.44 | -6.95 | 1.35 | 1.89 | - | ||
2021/8 | 0.49 | 18.33 | 13.35 | 2.98 | -9.53 | 1.23 | 2.09 | - | ||
2021/7 | 0.41 | 24.14 | 44.62 | 2.5 | -12.95 | 1.04 | 2.47 | - | ||
2021/6 | 0.33 | 11.37 | 3.17 | 2.09 | -19.27 | 1.06 | 2.48 | - | ||
2021/5 | 0.3 | -31.46 | 39.93 | 1.76 | -22.44 | 1.08 | 2.43 | - | ||
2021/4 | 0.43 | 23.54 | 53.06 | 1.46 | -28.89 | 1.14 | 2.31 | 去年同期因受新型冠狀病毒疫情影響,以致使營收銳減,今年疫情狀況好轉,營收回升。 | ||
2021/3 | 0.35 | -1.43 | -41.61 | 1.03 | -41.98 | 1.03 | 2.75 | - | ||
2021/2 | 0.36 | 10.81 | -28.48 | 0.68 | -42.17 | 1.17 | 2.41 | - | ||
2021/1 | 0.32 | -35.26 | -52.3 | 0.32 | -52.3 | 1.19 | 2.38 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/12 | 0.5 | 33.82 | -36.19 | 4.89 | -50.42 | 1.19 | 2.59 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/11 | 0.37 | 14.23 | -48.92 | 4.39 | -51.63 | 1.09 | 2.82 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/10 | 0.32 | -18.85 | -49.82 | 4.02 | -51.87 | 1.15 | 2.67 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/9 | 0.4 | -6.71 | -53.01 | 3.7 | -52.04 | 1.11 | 3.64 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/8 | 0.43 | 50.97 | -56.19 | 3.3 | -51.92 | 1.03 | 3.92 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/7 | 0.28 | -11.43 | -71.59 | 2.87 | -51.21 | 0.82 | 4.96 | 因受新型冠狀病毒疫情影響,致使營收波動。 | ||
2020/6 | 0.32 | 51.05 | -53.92 | 2.59 | -47.04 | 0.82 | 5.35 | 因受新型冠狀病毒疫情影響,致使營收下降。 | ||
2020/5 | 0.21 | -25.02 | -76.23 | 2.27 | -45.9 | 1.1 | 3.98 | 因受新型冠狀病毒疫情影響,致使營收下降。 | ||
2020/4 | 0.28 | -52.87 | -70.86 | 2.05 | -37.69 | 1.38 | 3.16 | 因受新型冠狀病毒疫情影響,致使營收下降。 | ||
2020/3 | 0.6 | 20.72 | -23.21 | 1.77 | -23.83 | 1.77 | 2.44 | - | ||
2020/2 | 0.5 | -26.09 | -34.85 | 1.17 | -24.14 | 1.95 | 2.22 | - | ||
2020/1 | 0.67 | -13.39 | -13.64 | 0.67 | -13.64 | 2.17 | 1.99 | - | ||
2019/12 | 0.78 | 7.11 | 2.97 | 9.86 | -19.58 | 2.15 | 2.16 | - | ||
2019/11 | 0.73 | 12.23 | -47.38 | 9.08 | -21.06 | 2.22 | 2.09 | - | ||
2019/10 | 0.65 | -24.01 | -57.69 | 8.36 | -17.48 | 2.47 | 1.88 | 主要係因中國市場營收衰退。 | ||
2019/9 | 0.85 | -13.03 | -23.81 | 7.71 | -10.34 | 2.83 | 1.92 | - | ||
2019/8 | 0.98 | -2.11 | 8.09 | 6.86 | -8.33 | 2.67 | 2.03 | - | ||
2019/7 | 1.0 | 43.66 | -15.09 | 5.88 | -10.58 | 2.59 | 2.1 | - | ||
2019/6 | 0.7 | -22.08 | -32.54 | 4.88 | -9.6 | 2.56 | 2.23 | - | ||
2019/5 | 0.89 | -8.09 | -7.38 | 4.19 | -4.19 | 0.0 | N/A | - | ||
2019/4 | 0.97 | 24.2 | 8.43 | 3.29 | -3.29 | 0.0 | N/A | - |